DIFICID

This brand name is authorized in Canada, United States

Active ingredients

The drug DIFICID contains one active pharmaceutical ingredient (API):

1 Fidaxomicin UNII Z5N076G8YQ - FIDAXOMICIN

Fidaxomicin is an antibiotic belonging to the macrocyclic class of antibacterials. Fidaxomicin is bactericidal and inhibits RNA synthesis by bacterial RNA polymerase. It interferes with RNA polymerase at a distinct site from that of rifamycins. Fidaxomicin is indicated for the treatment of Clostridioides difficile infections (CDI) also known as C. difficile-associated diarrhoea (CDAD) in adult and paediatric patients. Read about Fidaxomicin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DIFICID Film-coated tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A07AA12		A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07A Intestinal antiinfectives → A07AA Antibiotics
Discover more medicines within A07AA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02387174
Country: US	FDA, National Drug Code	Identifier(s): 52015-080, 52015-700